Background: Reduction mammoplasty is a well-established procedure that alleviates both physical and psychological symptoms associated with macromastia. Despite
its medical benefits, some insurance providers classify the procedure as primarily cosmetic or impose arbitrary weight criteria for reimbursement. This review explores
the relationship between excised tissue weight and symptomatic relief in patients undergoing reduction mammoplasty.

Objectives: To provide a comprehensive narrative synthesis of the literature regarding symptom improvement following reduction mammoplasty, regardless of excision
weight.
Methods: A literature review was conducted using PubMed and Google Scholar to identify relevant studies on reduction mammoplasty and its impact on symptoms. Key
studies were analyzed thematically to assess patterns and findings regarding symptom relief and its correlation with tissue resection weight.

Results: Across multiple studies, patients reported significant relief from macromastiarelated symptoms, including pain, postural discomfort, and psychosocial distress,
irrespective of the volume of breast tissue removed. Some studies suggested a correlation between larger resections and symptom relief, but the majority of the literature indicates that even smaller reductions can yield meaningful improvements. Additionally, factors such as body mass index (BMI) and preoperative symptom severity play a role in determining outcomes.
Conclusion: Given the consistent evidence of symptom relief independent of tissue resection weight, insurance providers should reconsider rigid weight-based criteria for coverage. Further research should focus on patient-reported outcomes and functional improvement as primary measures for determining the necessity of reduction mammoplasty